Navigation Links
FDA Grants Orphan Drug Status To Morphotek's Amatuximab (MORAb-009)
Date:11/12/2012

EXTON, Pa., Nov. 12, 2012 /PRNewswire/ -- Morphotek® Inc., a subsidiary of Eisai Inc., announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investigational cancer drug, amatuximab (MORAb-009) for the treatment of malignant pleural mesothelioma, the most common form of mesothelioma, which accounts for around 2,500 cases a year in the United States. This disease affects the pleura, which is the thin balloon shaped lining of the lungs.1

The Orphan Drug Act (ODA) allows FDA to grant orphan status to a drug which has the potential for the safe and effective treatment, diagnosis, or prevention of a rare disease/disorder that affects fewer than 200,000 people in the United States.2  Under the ODA, orphan designation qualifies the sponsor of the product for certain incentives, such as tax credits, prescription drug user fee waivers for the development product, and a seven year period of marketing exclusivity from the date of approval.

"We are very pleased to receive orphan drug designation for amatuximab for the potential treatment of malignant pleural mesothelioma," said Julia Maltzman, M.D., Senior Director of Clinical Development at Morphotek.  "We believe that addressing unmet medical needs, no matter the size of the patient population, is essential to the achievement of our human health care mission, which is to give first thought to patients and their families and to helping increase the benefits that health care provides.  Ultimately, this antibody has the potential to provide an additional treatment option for patients suffering from an extremely serious disease." 

Amatuximab (MORAb-009) is an investigational chimeric IgG1 antibody that targets a cell surface glycoprotein, mesothelin, which is over-expressed in a number of cancers. Mesothelin is thought to be involved in cell adhesion. Its presence
'/>"/>

SOURCE Morphotek Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... - Protecting the health and safety of Canadians is our government,s ... powers and tools at its disposal to help ensure that the ... To that end, Health Canada ... Canada of all drug products from three plants ... , Apotex Pharmachem India Pvt Ltd , Apotex Research ...
(Date:9/30/2014)... Sept. 30, 2014  Tasly Pharmaceuticals, Inc., the ... medicine, announced today the launch of Deepure. ... to address men and women concerned with supporting ... into old age while helping keep their health ... whole-food and herb-based formulas, namely, ProHeart PLUS, ImmunoPower ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds ... Brazil , Russia ... China (BRIC) will see robust expansion as ... favored over surgical procedures. Although revenues will be somewhat ... challenges, prolonged device approval times and demand for low-cost ...
Breaking Medicine Technology:Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3
(Date:10/2/2014)... Thompson HealthDay Reporter ... pull out all the stops to rescue surgical patients ... the cost of such heroism is questionable, a new ... percent better at saving elderly patients with life-threatening complications ... less intensity, said senior author Dr. Amir Ghaferi. He ...
(Date:10/1/2014)... more than 80 per cent of bowel cancers could ... that medicines called ,JAK inhibitors, halted tumour growth in ... in more than 80 per cent of bowel cancers. ... clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood ... second-most common cancer in Australia with nearly 17,000 people ...
(Date:10/1/2014)... 2014) Despite a policy focus on expanding ... this vulnerable population continues to have significant dental ... Journal of the American Dental Association , researchers ... University School of Dental Medicine report on the ... oral care provided by caregivers to adults with ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
Breaking Medicine News(10 mins):Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2
... University School of Medicine will add several new pediatric clinical rotations ... , ... North Brunswick, NJ (PRWEB) February 11, 2009-- ... will add several new pediatric clinical rotations to its growing network ...
... DaVita Inc.,(NYSE: DVA ) today announced results for ... the three months ended December 31, 2008 was $98.4,million, or ... per share,for the same period of 2007. , ... Net income for the year ended December 31, ...
... today reported significantly higher sales and earnings for both its fiscal third quarter and ... , Third quarter revenue increases 16% ... , Third quarter diluted EPS increases ... quarter of fiscal 2009, net sales increased 16 percent to $5,337,000 from $4,614,000 in ...
... First-Time AttendeesSTOWE, Vt., Feb. 10 The 9th Annual ... Learning for Survivors of All Cancers, and Those Who Love ... Stowe, Vermont, opens registration on February 24th, 2009.The Stowe ... has become one of the most inspiring, educational and unprecedented ...
... 10 Allscripts-Misys Healthcare,Solutions, Inc. ("Allscripts") announced today that ... under which Allscripts may purchase up to,$150 million of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... pursuant to Rule 10b5-1 or 10b-18 of the,Securities Exchange ...
... brain, researchers say , , TUESDAY, Feb. 10 (HealthDay News) ... don,t even bother to use them because they,re difficult ... nerves are allowing the brain to communicate directly with ... a banana and fold laundry. , "In the simplest ...
Cached Medicine News:Health News:Ross University School of Medicine Expands Clinical Rotations at Miami Children's Hospital 2Health News:DaVita 4th Quarter 2008 Results 2Health News:DaVita 4th Quarter 2008 Results 3Health News:DaVita 4th Quarter 2008 Results 4Health News:DaVita 4th Quarter 2008 Results 5Health News:DaVita 4th Quarter 2008 Results 6Health News:DaVita 4th Quarter 2008 Results 7Health News:DaVita 4th Quarter 2008 Results 8Health News:DaVita 4th Quarter 2008 Results 9Health News:DaVita 4th Quarter 2008 Results 10Health News:DaVita 4th Quarter 2008 Results 11Health News:DaVita 4th Quarter 2008 Results 12Health News:DaVita 4th Quarter 2008 Results 13Health News:DaVita 4th Quarter 2008 Results 14Health News:DaVita 4th Quarter 2008 Results 15Health News:DaVita 4th Quarter 2008 Results 16Health News:DaVita 4th Quarter 2008 Results 17Health News:DaVita 4th Quarter 2008 Results 18Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:9th Annual Stowe Weekend of Hope Registration Opens February 24 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 3Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 4Health News:New Technology May Boost Artificial Arms 2
End-gripping forceps with small, concentric rings on each tip. For general purpose membrane grasping, particularly thin membranes, or grasping membranes adherent to the retinal surface....
... design and developmerit of systems for the ... is pleased to present its latest system ... in one compact system. The D.O.R.C. VFI/VFE ... such as silicone oil, with viscosities of ...
... The D.O.R.C. HEXON Illumination System ... Xenon systems offer, with one remarkable ... discharge lamp, a more efficient source ... illumination quality provides a color consistency ...
... The EndoProbe handpieces, used for ... active aspiration, 25 gauge, and illuminating ... provides the ophthalmologist with uncompromised laser ... have 3-meter, fiber-optic cables that are ...
Medicine Products: